Total Payments
$24,465
2024 Payments
$398.89
Companies
26
Transactions
139
Medicare Patients
4,593
Medicare Billing
$916,801
Payment Breakdown by Category
Other$19,100 (78.1%)
Food & Beverage$3,951 (16.2%)
Travel$1,389 (5.7%)
Education$12.70 (0.1%)
Gifts$11.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,100 | 16 | 78.1% |
| Food and Beverage | $3,951 | 111 | 16.2% |
| Travel and Lodging | $1,389 | 10 | 5.7% |
| Education | $12.70 | 1 | 0.1% |
| Gift | $11.97 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $21,865 | 43 | $0 (2020) |
| Gilead Sciences, Inc. | $525.64 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $486.91 | 20 | $0 (2022) |
| AbbVie Inc. | $244.42 | 15 | $0 (2023) |
| GlaxoSmithKline, LLC. | $181.36 | 3 | $0 (2024) |
| ViiV Healthcare Company | $137.96 | 5 | $0 (2024) |
| TETRAPHASE PHARMACEUTICALS, INC. | $136.41 | 5 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $122.27 | 1 | $0 (2018) |
| Melinta Therapeutics, LLC | $108.80 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $108.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $398.89 | 10 | ViiV Healthcare Company ($137.96) |
| 2023 | $188.45 | 9 | Gilead Sciences, Inc. ($135.58) |
| 2022 | $180.66 | 12 | ABBVIE INC. ($132.97) |
| 2021 | $233.47 | 13 | AbbVie Inc. ($89.01) |
| 2020 | $2,782 | 20 | Allergan, Inc. ($2,588) |
| 2019 | $4,041 | 20 | Allergan Inc. ($3,615) |
| 2018 | $5,049 | 18 | Allergan Inc. ($4,598) |
| 2017 | $11,591 | 37 | Allergan Inc. ($11,063) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: HCV | ||||||
| 10/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: HIV | ||||||
| 08/17/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: HIV | ||||||
| 08/06/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Automated insulin delivery system | ||||||
| 07/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: HIV | ||||||
| 07/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 07/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: HIV | ||||||
| 04/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.82 | General |
| 11/26/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 11/01/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.87 | General |
| 07/20/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.32 | General |
| 06/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.92 | General |
| 05/26/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.74 | General |
| 04/05/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: WATCHMAN_IC | ||||||
| 04/05/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: rezum_URO | ||||||
| 03/08/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $76.50 | General |
| Category: HCV | ||||||
| 11/22/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: VIROLOGY | ||||||
| 10/27/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: VIROLOGY | ||||||
| 10/25/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/25/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: VIROLOGY | ||||||
| 06/07/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/09/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Infections and Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 929 | 3,171 | $602,175 | $205,405 |
| 2022 | 9 | 975 | 3,275 | $465,553 | $190,912 |
| 2021 | 8 | 1,287 | 4,247 | $573,200 | $253,199 |
| 2020 | 8 | 1,402 | 4,700 | $626,932 | $267,285 |
Total Patients
4,593
Total Services
15,393
Medicare Billing
$916,801
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 255 | 1,446 | $252,735 | $87,892 | 34.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 98 | 349 | $87,130 | $31,944 | 36.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 120 | 800 | $120,000 | $30,712 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 222 | 267 | $66,750 | $26,679 | 40.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 77 | $28,490 | $10,289 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 92 | $22,080 | $8,227 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 106 | $16,960 | $6,862 | 40.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 22 | $4,070 | $1,412 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,960 | $1,388 | 35.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 274 | 1,405 | $186,205 | $80,358 | 43.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 186 | 1,110 | $112,650 | $34,539 | 30.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 223 | 270 | $65,590 | $29,588 | 45.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 247 | $45,700 | $20,164 | 44.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 70 | 73 | $24,070 | $11,447 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 74 | $14,306 | $6,797 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 31 | $4,836 | $2,163 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 15 | $4,708 | $2,084 | 44.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 24 | 25 | $4,135 | $2,030 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 25 | $3,353 | $1,741 | 51.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 438 | 1,751 | $227,630 | $106,160 | 46.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 264 | 1,593 | $159,300 | $51,944 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 345 | 415 | $99,600 | $47,819 | 48.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 69 | 280 | $44,800 | $24,341 | 54.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 59 | $17,700 | $9,896 | 55.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 57 | 81 | $12,636 | $6,314 | 50.0% |
About Dr. Munir Shah, MD
Dr. Munir Shah, MD is a Internal Medicine healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437240611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Munir Shah, MD has received a total of $24,465 in payments from pharmaceutical and medical device companies, with $398.89 received in 2024. These payments were reported across 139 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,100).
As a Medicare-enrolled provider, Shah has provided services to 4,593 Medicare beneficiaries, totaling 15,393 services with total Medicare billing of $916,801. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Maumee, OH
- Active Since 09/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437240611
Products in Payments
- AVYCAZ (Drug) $12,892
- DALVANCE (Drug) $8,718
- TEFLARO (Drug) $440.56
- Epclusa (Drug) $234.25
- ZERBAXA (Drug) $168.54
- DOVATO (Drug) $137.96
- Xerava (Drug) $122.97
- AREXVY (Drug) $122.55
- UTIBRON (Drug) $122.27
- DIFICID (Drug) $121.47
- INVOKANA (Drug) $108.10
- Vascepa (Drug) $101.57
- STEGLATRO (Drug) $89.62
- Orbactiv (Drug) $64.01
- ISENTRESS (Drug) $58.69
- MAVYRET (Drug) $58.54
- XERAVA (Drug) $53.02
- Tresiba (Drug) $51.04
- BELSOMRA (Drug) $48.59
- INCRUSE (Drug) $46.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Maumee
Dr. Nizar Daboul, M.d, M.D
Internal Medicine — Payments: $88,959
Internal Medicine $88,959
Dr. Nidaa Khamousia, M.d, M.D
Internal Medicine — Payments: $17,349
Internal Medicine $17,349
Richard Paat, M.d, M.D
Internal Medicine — Payments: $1,143
Internal Medicine $1,143
Allen Schwisow, M.d, M.D
Internal Medicine — Payments: $888.56
Internal Medicine $888.56
Jamal Saleh, M.d, M.D
Internal Medicine — Payments: $244.81
Internal Medicine $244.81
Robert Stierwalt, Md, MD
Internal Medicine — Payments: $128.80
Internal Medicine $128.80